Yu Ren

2.9k total citations
123 papers, 2.0k citations indexed

About

Yu Ren is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yu Ren has authored 123 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 39 papers in Cancer Research and 27 papers in Oncology. Recurrent topics in Yu Ren's work include Breast Cancer Treatment Studies (14 papers), Ferroptosis and cancer prognosis (12 papers) and Breast Lesions and Carcinomas (10 papers). Yu Ren is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Ferroptosis and cancer prognosis (12 papers) and Breast Lesions and Carcinomas (10 papers). Yu Ren collaborates with scholars based in China, United States and United Kingdom. Yu Ren's co-authors include Jianjun He, Peijun Liu, Xubo Yuan, Ke Wang, Can Zhou, Xuan Zhou, Juan Li, Yang Liu, Yuhui Zhou and Ke Wang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yu Ren

109 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Ren China 28 992 656 420 337 282 123 2.0k
Min Li China 29 1.4k 1.4× 598 0.9× 401 1.0× 462 1.4× 297 1.1× 139 2.8k
Xiru Li China 25 895 0.9× 561 0.9× 371 0.9× 229 0.7× 181 0.6× 102 2.0k
Rui Huang China 28 1.2k 1.2× 724 1.1× 673 1.6× 482 1.4× 335 1.2× 178 2.4k
Jing Hao China 25 1.3k 1.3× 491 0.7× 293 0.7× 210 0.6× 260 0.9× 116 2.3k
Wei He China 27 1.3k 1.3× 797 1.2× 558 1.3× 526 1.6× 338 1.2× 134 2.9k
Shuang Liu China 25 1.1k 1.1× 626 1.0× 541 1.3× 272 0.8× 255 0.9× 132 2.3k
Yiping Wu China 27 1.5k 1.5× 809 1.2× 454 1.1× 197 0.6× 249 0.9× 123 2.7k
Wenjun Yang China 24 790 0.8× 486 0.7× 328 0.8× 233 0.7× 185 0.7× 119 1.9k
Xi Lin China 32 1.4k 1.4× 887 1.4× 390 0.9× 320 0.9× 236 0.8× 90 2.9k
Yu‐Chan Chang Taiwan 30 1.3k 1.3× 842 1.3× 405 1.0× 305 0.9× 205 0.7× 109 2.5k

Countries citing papers authored by Yu Ren

Since Specialization
Citations

This map shows the geographic impact of Yu Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Ren more than expected).

Fields of papers citing papers by Yu Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Ren. The network helps show where Yu Ren may publish in the future.

Co-authorship network of co-authors of Yu Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Ren. A scholar is included among the top collaborators of Yu Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Ren. Yu Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ren, Yu, Yuhang Dong, Keying Xu, et al.. (2025). Kidney-targeting DNA tetrahedral molecular cage synergistically inhibits acute kidney injury by clearing ROS and activating HO-1. Biomaterials. 320. 123237–123237. 2 indexed citations
3.
4.
5.
Ren, Yu, Xiongfei Liu, & Yi Zhu. (2024). Incremental marketization reforms and venture capital strategy adjustments: Based on industrial chain innovation development. Finance research letters. 70. 106346–106346. 1 indexed citations
6.
Liu, Yi, et al.. (2024). LncRNA DLG5-AS1 facilitates breast cancer cell proliferation and invasion by promoting EZH2-mediated transcriptional silencing of SFRP1. Archives of Biochemistry and Biophysics. 756. 110018–110018. 2 indexed citations
7.
8.
Zhang, Shaolin, Hua Ding, Yuwei Deng, et al.. (2024). TTK promotes HER2 + breast cancer cell migration, apoptosis, and resistance to targeted therapy by modulating the Akt/mTOR axis. Journal of Cancer Research and Clinical Oncology. 150(12). 512–512.
9.
Wang, Bo, Zheyong Liang, Tan Tan, et al.. (2023). CRB3 navigates Rab11 trafficking vesicles to promote γTuRC assembly during ciliogenesis. eLife. 12. 1 indexed citations
10.
Wang, Bo, Zheyong Liang, Tan Tan, et al.. (2023). CRB3 navigates Rab11 trafficking vesicles to promote γTuRC assembly during ciliogenesis. eLife. 12. 2 indexed citations
11.
Wang, Bo, Lu Yang, Miao Zhang, et al.. (2022). FMNL2 suppresses cell migration and invasion of breast cancer: a reduction of cytoplasmic p27 via RhoA/LIMK/Cofilin pathway. Cell Death Discovery. 8(1). 155–155. 5 indexed citations
12.
Liu, Chao, Yining Li, Ren Sheng, et al.. (2021). Synthesis of N-methylpyridine-chlorofuranformamide analogs as novel OPG up-regulators and inhibitors of RANKL-induced osteoclastogenesis. Bioorganic Chemistry. 116. 105361–105361. 2 indexed citations
13.
Ren, Yu, et al.. (2020). Fluorescence spectra of nutrients in chicken and skin under baking conditions. Optik. 218. 164795–164795. 1 indexed citations
14.
Wang, Bin, Siyuan Jiang, Lizhe Zhu, et al.. (2020). <p>A Nomogram to Predict the Probability of Breast Intraductal Tumors in Patients with Nipple Discharge: A Real-World Study Based on Our 13-Year Clinical Experience</p>. Cancer Management and Research. Volume 12. 11191–11201. 1 indexed citations
15.
16.
Zhu, Lizhe, Nan Ma, Bin Wang, et al.. (2019). <p>Significant prognostic values of aquaporin mRNA expression in breast cancer</p>. Cancer Management and Research. Volume 11. 1503–1515. 36 indexed citations
17.
Chen, Xiaohong, Feng Chen, Yu Ren, et al.. (2019). Glucocorticoid receptor upregulation increases radioresistance and triggers androgen independence of prostate cancer. The Prostate. 79(12). 1414–1426. 14 indexed citations
18.
Wang, Yi, et al.. (2018). Vascular activity of protopanaxadiol and protopanaxatriol, the major saponin fractions isolated from roots of Panax notoginseng. Mount Kenya University E-Repository (Mount Kenya University). 1 indexed citations
19.
Mao, Xiaona, Pingping Li, Yaochun Wang, et al.. (2017). CRB3 regulates contact inhibition by activating the Hippo pathway in mammary epithelial cells. Cell Death and Disease. 8(1). e2546–e2546. 36 indexed citations
20.
Ge, Guanqun, Can Zhou, Yu Ren, et al.. (2015). Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling. Tumor Biology. 37(4). 5049–5062. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min Li Breakdown of academic impact, for papers by Xiru Li Breakdown of academic impact, for papers by Rui Huang Breakdown of academic impact, for papers by Jing Hao Breakdown of academic impact, for papers by Wei He Breakdown of academic impact, for papers by Shuang Liu Breakdown of academic impact, for papers by Yiping Wu Breakdown of academic impact, for papers by Wenjun Yang Breakdown of academic impact, for papers by Xi Lin Breakdown of academic impact, for papers by Yu‐Chan Chang
Rankless by CCL
2026